By Counterforce Health Team in Firazyr (icatibant injection) —

How to Get Firazyr (Icatibant Injection) Covered by Aetna CVS Health in Pennsylvania: Complete Appeals Guide

Answer Box: Firazyr (icatibant injection) is excluded from most Aetna CVS Health formularies in Pennsylvania, requiring a formulary exception with documented medical necessity. Start by having your HAE specialist submit a prior authorization request with attack history, diagnosis confirmation, and evidence of alternative therapy failures. If denied, Pennsylvania's new external review program overturns about 50% of appeals. First step: Contact Aetna at 1-855-240-0536 to verify your plan's formulary status and obtain the current PA forms.

Table of Contents

Coverage Basics: Is Firazyr Covered by Aetna CVS Health?

Short answer: Not routinely. Firazyr (icatibant injection) is excluded from Aetna's 2024 Advanced Control and Standard Control formularies, meaning most commercial members must pay full cost unless they obtain a formulary exception.

Coverage at a Glance

Requirement What It Means Where to Find It
Formulary Status Excluded from most plans Aetna 2024 Exclusion Lists
Prior Authorization Required for exceptions Aetna PA Forms
Specialist Required HAE specialist must prescribe Aetna Clinical Policy
Quantity Limits Up to 3 syringes per month Aetna Quantity Limits
Pharmacy Network CVS Specialty required Contact CVS Specialty: 1-800-237-2767
Note: Medicare Advantage plans may have different coverage. Check your specific plan formulary through Aetna Medicare.

Prior Authorization Process: Who Submits and How

Step-by-Step: Fastest Path to Approval

  1. Verify Coverage (Patient/Clinic)
    • Call Aetna: 1-855-240-0536
    • Confirm formulary status for your specific plan
    • Request current PA forms
  2. Gather Documentation (Clinic)
    • HAE diagnosis confirmation with lab results
    • Attack frequency and severity records
    • Prior therapy trials and failures
    • Self-administration training documentation
  3. Submit PA Request (Prescriber)
  4. Request Peer-to-Peer (If Needed)
    • HAE specialist speaks directly with Aetna medical director
    • Can expedite complex cases
    • Schedule through provider services
  5. Appeal if Denied (Patient/Clinic)
    • Internal appeal within 180 days
    • Pennsylvania external review if internal appeals fail
    • Expedited process available for urgent cases

Clinician Corner: Medical Necessity Letter Checklist

Your medical necessity letter should include:

  • Diagnosis: Confirmed HAE with genetic/lab evidence
  • Attack History: Frequency, severity, impact on daily life
  • Prior Treatments: Specific therapies tried, duration, outcomes
  • Clinical Rationale: Why Firazyr is appropriate vs. alternatives
  • Guidelines: Reference FDA labeling and HAE treatment guidelines
  • Self-Administration: Documentation of completed training

Timeline: How Long Does Approval Take?

Standard Process Timeline

  • PA Submission to Decision: 30-45 days
  • Internal Appeal: 30 days for decision
  • Expedited Appeal: 72 hours for urgent cases
  • Pennsylvania External Review: 45 days (standard) or 72 hours (expedited)
Tip: For active HAE attacks, request expedited review citing urgent medical need.

Medical Necessity Criteria

Aetna typically requires documentation of:

Diagnosis Requirements

  • Confirmed HAE diagnosis (Type I, II, or III)
  • Laboratory evidence of C1-esterase inhibitor deficiency or genetic testing
  • Clinical history consistent with HAE attacks

Treatment History

  • Evidence of inadequate response to preferred alternatives
  • Documentation of contraindications to other HAE therapies
  • Attack frequency justifying on-demand therapy

Prescriber Qualifications

  • Board-certified immunologist, allergist, or hematologist
  • Physician with documented HAE management experience
  • Consultation notes if not primary prescriber

Self-Administration Training

  • Completed training by healthcare professional
  • Documentation of proper injection technique
  • Patient understanding of dosing (max 3 doses per 24 hours)

Cost Considerations

Out-of-Pocket Costs

  • Wholesale Acquisition Cost: ~$11,147 per syringe
  • Typical Copay: Varies by plan; often subject to specialty tier coinsurance

Cost-Saving Options

  1. Takeda Patient Support Program
    • Copay assistance for eligible commercial insurance patients
    • May cover up to 100% of copay
    • Enroll at TakedaPatientSupport.com or call 1-866-888-0660
  2. Generic Icatibant
    • May be preferred alternative with lower cost
    • Same active ingredient as Firazyr
  3. Alternative HAE Therapies
    • C1-INH concentrates (Berinert, Ruconest)
    • Ecallantide (Kalbitor)
    • May have different coverage status

Common Denial Reasons and Appeals

Most Common Aetna Denial Reasons

Denial Reason How to Overturn
Non-formulary Request formulary exception with medical necessity documentation
Lack of HAE diagnosis Submit lab results, genetic testing, specialist confirmation
Insufficient attack history Provide detailed attack logs, ER visits, impact documentation
Missing specialist Ensure prescriber is HAE specialist or provide consultation notes
No self-admin training Document completed training by healthcare provider
Quantity limits exceeded Justify higher need with attack frequency data

Appeals Playbook for Aetna CVS Health in Pennsylvania

Level 1: Internal Appeal

  • Deadline: 180 days from denial
  • How to File: Aetna member portal or mail
  • Timeline: 30 days for decision
  • Required: Denial letter, additional medical records, prescriber letter

Level 2: Pennsylvania External Review

  • Eligibility: After final internal denial
  • Deadline: 4 months from final denial letter
  • How to File: Pennsylvania Insurance Department
  • Success Rate: ~50% of denials overturned in 2024
  • Timeline: 45 days (standard) or 72 hours (expedited)
From Our Advocates: We've seen HAE patients succeed in Pennsylvania external reviews by submitting comprehensive attack diaries spanning 6-12 months, detailed specialist letters explaining why alternatives failed, and FDA labeling excerpts highlighting Firazyr's specific indication for acute attacks. The key is painting a complete picture of medical necessity.

Pennsylvania External Review Program

Pennsylvania launched its Independent External Review Program in January 2024, offering new hope for patients facing Aetna denials. The program has shown promising results with about 50% of appeals overturned.

Key Features

  • Independent Review: Board-certified physicians review cases
  • Binding Decisions: Aetna must comply with IRO determinations
  • No Cost: Free to patients
  • Additional Evidence: 15 days to submit extra documentation

How to File

  1. Obtain final denial letter from Aetna
  2. Complete Pennsylvania external review forms
  3. Submit within 4 months of final denial
  4. Provide all medical records and supporting evidence

Contact Information

  • Pennsylvania Insurance Department Consumer Services: (verify phone number at pa.gov)
  • Online Portal: Available at pa.gov for electronic submissions

Specialty Pharmacy Requirements

Aetna requires Firazyr to be dispensed through CVS Specialty Pharmacy for most plans.

CVS Specialty Process

  • Phone: 1-800-237-2767
  • Services: Coordination with prescribers, insurance verification, patient support
  • Delivery: Direct to patient with temperature-controlled shipping
  • Training: Injection technique support and educational materials
Note: Using non-preferred specialty pharmacies may result in higher costs or coverage denial.

Troubleshooting Common Issues

Portal Access Problems

  • Clear browser cache and cookies
  • Try different browser or incognito mode
  • Contact Aetna technical support: 1-855-240-0536

Missing Forms or Documentation

Delayed Responses

  • Follow up after 30 days for standard PA
  • Request expedited review for urgent cases
  • Escalate to Pennsylvania Insurance Department if needed

FAQ

Q: How long does Aetna PA take in Pennsylvania? A: Standard prior authorization takes 30-45 days. Expedited reviews for urgent cases are completed within 72 hours.

Q: What if Firazyr is non-formulary on my plan? A: You can request a formulary exception with documented medical necessity. This requires comprehensive clinical justification from your HAE specialist.

Q: Can I request an expedited appeal? A: Yes, if you have an urgent medical condition. Active HAE attacks or high attack frequency may qualify for expedited 72-hour review.

Q: Does step therapy apply if I've tried alternatives outside Pennsylvania? A: Yes, Aetna typically accepts prior therapy documentation from any location, but ensure records are complete and transferred to your current provider.

Q: What's the difference between internal and external appeals? A: Internal appeals are reviewed by Aetna staff, while Pennsylvania external reviews use independent physician reviewers. External reviews have higher success rates (~50% vs. lower internal rates).

Q: How much does Firazyr cost without insurance? A: Approximately $11,147 per syringe. Takeda's patient assistance program may help eligible patients with commercial insurance reduce costs.

Q: Can family members help with the appeal process? A: Yes, with proper authorization forms. Caregivers can assist with documentation gathering and communication with insurers.

Q: What happens if my appeal is successful? A: Aetna must provide coverage immediately, including retroactive coverage if you paid out-of-pocket during the appeal process.

Getting personalized help with your Firazyr appeal can make the difference between approval and denial. Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to craft point-by-point rebuttals aligned with each payer's specific requirements. Their platform identifies denial reasons and drafts appeals with the right medical evidence and procedural requirements for your situation.

For additional support, Pennsylvania residents can contact the Pennsylvania Insurance Department Consumer Services or the Pennsylvania Health Law Project for free assistance with complex appeals.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Coverage policies and requirements may change. Always verify current information with Aetna CVS Health and consult with your healthcare provider about treatment decisions. For official appeals guidance, contact the Pennsylvania Insurance Department.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.